基于血清学与超声的卵巢肿块恶性预测列线图
回顾性分析1277例卵巢肿块患者,构建基于年龄、CA125、纤维蛋白原白蛋白比、单核细胞淋巴细胞比及超声的列线图,AUC为0.937,验证队列AUC为0.925(cut-off 0.298),优于现有模型且对早期癌有识别价值。
要点
- 列线图纳入年龄、CA125、FAR、MLR及超声结果,术前预测卵巢肿块恶性。
- 建模队列AUC 0.937(95%CI 0.920-0.954),验证队列AUC 0.925(95%CI 0.896-0.953)。
- 该模型在早期卵巢癌识别方面显示潜在价值。
核心结论
- 该经济便捷的列线图模型对卵巢肿块术前恶性预测具有良好准确性,甚至可用于早期阶段。
研究设计与样本
- 回顾性分析1277例卵巢肿块患者,采用ROC分析筛选预测因子,单因素及多因素logistic回归识别卵巢癌风险因素,构建列线图并在验证队列中评估校准度与区分度,用DCA评估临床净获益。
主要发现
- 496例(38.8%)为卵巢癌。
- 年龄、CA125、纤维蛋白原白蛋白比、单核细胞淋巴细胞比及超声结果为最优预测参数。
- 列线图建模队列AUC 0.937(95%CI 0.920-0.954)。
- 验证队列校准良好,cut-off 0.298时AUC 0.925(95%CI 0.896-0.953)。
关键数值与推荐
- 列线图验证队列cut-off点为0.298,对应AUC 0.925(95%CI 0.896-0.953)。
临床怎么用
- 可用于卵巢肿块患者术前恶性风险评估,辅助临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a novel diagnostic nomogram model to predict malignancy in patients with ovarian masses. METHODS: In total, 1277 patients with ovarian masses were retrospectively analyzed. Receiver operating characteristic (ROC) analysis was performed to identify valuable predictive factors. Univariate and multivariate logistic regression analyses were used to identify risk factors for ovarian cancer. Subsequently, a predictive nomogram model was developed. The performance of the nomogram model was assessed by its calibration and discrimination in a validation cohort. Decision curve analysis (DCA) was applied to assess the clinical net benefit of the model. RESULTS: Overall, 496 patients (38.8%) had ovarian cancer. Eighteen parameters were significantly different between the malignant and benign groups. Five parameters were identified as being most optimal for predicting malignancy, including age, carbohydrate antigen 125, fibrinogen-to-albumin ratio, monocyte-to-lymphocyte ratio, and ultrasound result. These parameters were incorporated to establish a nomogram model, and this model exhibited an area under the ROC curve (AUC) of 0.937 (95% confidence interval [CI], 0.920-0.954). The model was also well calibrated in the validation cohort and showed an AUC of 0.925 (95%CI, 0.896-0.953) at the cut-off point of 0.298. DCA confirmed that the nomogram model achieved the best clinical utility with almost the entire range of threshold probabilities. The model has demonstrated superior efficacy in predicting malignancy compared to currently available models, including the risk of ovarian malignancy algorithm, copenhagen index, and the risk of malignancy index. More importantly, the nomogram established here showed potential value in identification of early-stage ovarian cancer. CONCLUSION: The cost-effective and easily accessible nomogram model exhibited favorable accuracy for preoperative prediction of malignancy in patients with ovarian masses, even at early stages.
引用
- Guo Y, Jiang T, Ouyang L, et al. A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses. Gynecol Oncol. 2020. PMID: 33357959. doi:10.1016/j.ygyno.2020.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。